FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

736633008: Neratinib maleate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3520528010 Neratinib maleate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3520529019 Neratinib maleate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
5496041000241112 maléate de nératinib fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Neratinib maleate (substance) Is a Neratinib (substance) false Inferred relationship Some
Neratinib maleate (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Protein-tyrosine kinase inhibitor (disposition) true Inferred relationship Some
Neratinib maleate (substance) Is a Nitrile true Inferred relationship Some
Neratinib maleate (substance) Is a Enzyme inhibitor false Inferred relationship Some
Neratinib maleate (substance) Is a Quinoline true Inferred relationship Some
Neratinib maleate (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Neratinib (substance) true Inferred relationship Some
Neratinib maleate (substance) Is a Protein-tyrosine kinase inhibitor true Inferred relationship Some
Neratinib maleate (substance) Is a Antineoplastic agent (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely neratinib (as neratinib maleate) 40 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Neratinib maleate (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start